Effects of perfluorocarbon on lipopolysaccharide-induced intercellular adhesion molecule-1 expression in cultured pulmonary microvascular endothelial cells Source: Eur Respir J 2007; 30: Suppl. 51, 295s Year: 2007
Overnight change of circulating intercellular adhesion molecule-1 levels in children with sleep disordered breathing Source: Eur Respir J 2006; 28: Suppl. 50, 533s Year: 2006
Soluble intercellular adhesion molecule-1 and E-selectin in patients with asthma exacerbation Source: Annual Congress 2009 - Inflammation and airways Year: 2009
The role of soluble intercellular adhesion molecule-1 (sICAM-1) in progress of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007
Serum level of soluble vascular cell adhesion molecule-1 (sVCAM-1) in bronchial asthma in children Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Bosutinib protects against pulmonary vascular leakage by improving endothelial cell-matrix adhesion Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019
Soluble form of intercellular adhesion molecule-1 as a serum marker of inflammation activity in cryptogenic fibrosing alveolitis Source: Eur Respir J 2004; 24: Suppl. 48, 356s Year: 2004
Vascular cell adhesion molecule I (VCAM-1) expression in pulmonary leptospirosis Source: Eur Respir J 2007; 30: Suppl. 51, 722s Year: 2007
VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeability Source: Eur Respir J, 58 (4) 2004518; 10.1183/13993003.04518-2020 Year: 2021
Vascular endothelial growth factor in sleep apnea syndrome and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 362s Year: 2005
PTEN reduces vascular endothelial growth factor–mediated vascular permeability in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005
Decreased circulating endothelial progenitor cells in obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8 Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Vascular endothelial growth factor (VEGF) and airway inflammation in COPD. Correlation with pulmonary function Source: Eur Respir J 2006; 28: Suppl. 50, 653s Year: 2006
Influence of micropaticles harvested from patients affected by obstructive sleep apnea syndrome on endothelial function and vascular reactivity Source: Annual Congress 2009 - Pathogenesis of sleep-disordered breathing Year: 2009
Imbalance between vascular endothelial growth factor and endostatin in emphysema Source: Eur Respir J 2003 Oct 01;22(4):609-612 Year: 2003
Soluble VE-cadherin: not just a marker of endothelial permeability Source: Eur Respir J, 58 (6) 2102241; 10.1183/13993003.02241-2021 Year: 2021
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010